CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,052 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04034992
NCT04034992N/ACompleted

An Observational Study Collecting Real-world Data on Patients With Chronic Kidney Disease to Assess: Early Treatment Experience, Treatment Patterns, Treatment Effectiveness, Patient Outcomes and Patient Quality of Life Through Prospective and Retrospective Data Capture

AstraZeneca·observational·Posted Jul 29, 2019·Updated Mar 6, 2024

In Brief

An observational study for Chronic Kidney Disease. Completed, enrolled 1,052 participants across 43 sites in 6 countries.

Detailed Summary

DISCOVER CKD is an international observational cohort study in patients with CKD, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hypotheses, is largely descriptive, and utilises data collected only under conditions of routine clinical care.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly, Japan, Spain, Sweden, United Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJul 29, 2019
Enrollment StartSep 11, 2019
Primary CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 6.9 years ago